Cargando…
Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis
INTRODUCTION: In hemodialysis patients, coronavirus disease 2019 is associated with high morbidity and mortality. Aim of the study was to evaluate the antibody level against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients treated with two different mRNA-based vaccines, in a...
Autores principales: | Ionita, Cristian, Marcelli, Daniele, Nita, Cristian, Anton, Carmen, Berca, Suzana, Vacar, Smaranda, Schiller, Oana, Gheorghiu, Carmen, Barth, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720556/ https://www.ncbi.nlm.nih.gov/pubmed/34978050 http://dx.doi.org/10.1007/s40620-021-01195-8 |
Ejemplares similares
-
Absence of Antibody Reponses and Severe COVID-19 in Patients on Hemodialysis Following mRNA Vaccination
por: Michael, Miriam B, et al.
Publicado: (2021) -
Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzate
por: Zhang, Li, et al.
Publicado: (2021) -
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
por: Kanji, Jamil N., et al.
Publicado: (2021) -
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
por: Quiroga, Borja, et al.
Publicado: (2022) -
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study
por: Chang, Yi-Shin, et al.
Publicado: (2023)